Screen-Printed Biosensors for the Early Detection of Biomarkers Related to Alzheimer Disease: Preliminary Results

Alzheimer disease (AD), despite representing the most common type of dementia in elderly, is still lacking reliable methodologies for early diagnosis. A potential biomarker associated to AD development has been recently identified in the open isoform of p53, redox sensitive protein, currently quantified using a specific blood-based enzyme-linked immunosorbent assay (ELISA). In order to overcome ELISA limitations (level of detection, standardization and reliability), this study aimed to realize a low cost highly sensitive portable point-of-care (PoC) testing system based on screen printed electrochemical sensors (SPES). The study specifically reported the design of the platform, including the sensing probe and the electronic circuit devoted to the conditioning of the electric signal. Preliminary results were obtained from circuit testing by using controlled concentrations of electrolytic solutions and from an initial calibration stage by using Anodic Stripping Voltammetry (ASV) measurements. Future works will address the quantification of unknown concentration of unfolded p53 in peripheral blood samples, thus to validate the here-presented low cost, easy to use and highly precise platform.